Clinical Trials Browser

Has results × Neuroendocrine Tumors × TH 302 × Clear all

NCT02402062 2020-07-27

A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours

Phase 2 Completed

17 enrolled 55 charts

EndocrineGastrointestinalNET

Pancreatic Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors